6 TECH OUTLOOKFebruary 2016Copyright © 2015 Valley Media Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.FEBRUARY - 2016Mailing AddressValley Media Inc.44790 S. Grimmer Blvd Suite 202, Fremont, CA 94538T:510 230 0396, F:510-894-8405 FEBRUARY - 2016, Vol 02 - 02 Published by Valley Media Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Editor-in-ChiefStacey SmithEditorial StaffSalesVisualizerStephen ThomasArun ThomasAaron Pierce Aishwarya KannanAlex D'SouzaAva GarciaJenna VegasJoshua ParkerEnterprise Software SpecialRichard Rodriguez richard.a@pharmatechoutlook.comEditorialStacey Smith Editor-in-ChiefThe pharmaceutical industry is poised to undergo radical changes this year. From increased market demand to stricter legislation and patent cliffs, pharmaceutical companies will need new strategies to make the most of the industry trends. There is a demand for more flexible and efficient pharmaceutical enterprise software solutions that use advanced technology to meet the challenges head-on. Specifically with supply chain management, pharmaceutical distributers must move products to their customers faster while maintaining lower inventory levels. In such situations, a robust suite of pharmaceutical enterprise resource planning software will help improve supply chain management, customer relations, vendor agreements, identification of slow moving, and out of stock items, and inventory data.Meanwhile, drug prices, rising medical costs, and telemedicine are the trends expected to hit patients directly this year. As the industry copes with the continued influx of the newly insured, the rising burden of medical costs, and a host of new technologies, startups and even larger companies are looking for novel ways to reach customers.Irrespective of the road the companies decide to take with regard to pricing, the persistent growth of data is ushering in master data management as something that every marketing leader needs to address in order to improve pharmaceutical sales. Besides just impacting sales and marketing, data is transforming the way new drugs are developed. What arises as the prime need in such an hour? Analytics technologies tailored to the needs of the pharmaceutical industry. State-of-the-art pharma analytics tools can help executives make the right decisions and increase revenue by optimizing innovation, improving the efficiency of research and clinical trials, and building new tools for physicians. This presents a compelling opportunity for enterprises to explore the full potential of big data.While 2016 seems to be a challenging year for pharmaceutical companies, new opportunities will emerge amid these paradigm shifts. On that note, Pharma Tech Outlook presents to you its Enterprise Software special edition featuring technology insights that will help you better adapt to the changing landscape.We hope this edition is a worthy companion in your enterprise endeavors. Let us know your thoughts.Get Ready for a Shake-UpTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >